Therapy News and Research

RSS

Migraine patients may benefit from green light therapy

New research from the University of Arizona Health Sciences found that people who suffer from migraine may benefit from green light therapy, which was shown to reduce the frequency and intensity of headaches and improve patient quality of life.

10 Sep 2020

Intravenous iron therapy does not benefit anemic patients during surgery, study finds

A global study led by researchers at The University of Western Australia has addressed the rising use of intravenous iron therapy in anemic patients during major surgery and found there is little benefit.

10 Sep 2020

Convalescent plasma fails to improve outcome of COVID-19 in India

A new study based in India and published on the medRxiv preprint server explores the role of convalescent plasma (CP) in the treatment of moderate COVID-19 within the limitations on resources faced in a developing country.

9 Sep 2020

Combination of stem cell therapy and educational intervention can help kids with ASD

Results of a clinical trial released today in STEM CELLS Translational Medicine indicate that a combination of stem cell therapy and educational intervention can significantly help children with autism spectrum disorder (ASD).

9 Sep 2020

Protein aggregation reduces elasticity of blood vessels in the brain

Deposits of a protein called "Medin", which manifest in virtually all older adults, reduce the elasticity of blood vessels during aging and hence may be a risk factor for vascular dementia.

9 Sep 2020

Novel drug could improve life expectancy and quality for patients with hard-to-treat cancers

The Sheffield researchers founded the spin-out Modulus Oncology with a team of experienced biotech entrepreneurs to fast-track the drug into clinical testing within two years.

9 Sep 2020

High-intensity focused ultrasound technology shows promising outcomes for prostate cancer

High-intensity focused ultrasound (HIFU) - a technology used to treat localized prostate cancer - has shown adequate control of prostate cancer while avoiding major side effects of surgery or radiation therapy, according to a new study in The Journal of Urology®, Official Journal of the American Urological Association (AUA).

9 Sep 2020

New drug can enhance life expectancy and quality for patients with hard-to-treat cancers

A new drug which could improve life expectancy and quality for patients with hard-to-treat cancers, such as pancreatic cancer and relapsed breast cancer, has been invented by scientists at the University of Sheffield.

9 Sep 2020

New combination therapy helps fight cancer

Radiation causes key changes to immune cells in kidney cancer tumors.T cells in tumors are expanded in blood shortly after radiation, then decrease.

9 Sep 2020

Environmental and biomedical applications of enzyme inhibitors

Enzyme inhibitors play a pivotal role in pharmaceutical and nutraceutical industries. The primary understanding of the action of inhibitors helps pharmacologists during the design process for developing new therapeutic drugs.

8 Sep 2020

Targeted therapy can provide benefits to lung cancer patients with specific gene mutations

A targeted therapy called capmatinib can provide significant benefits to patients who have advanced lung cancer with specific gene mutations, according to recently published results from a phase two clinical trial.

8 Sep 2020

Scientists develop a rapid, reliable and low-cost COVID-19 antibody test

Robust and widespread antibody testing has emerged as a key strategy in the fight against SARS-CoV-2, the virus responsible for the COVID-19 pandemic.

8 Sep 2020

Study reveals complex immunology behind MIS-C in children with COVID-19

In a recent paper published in the prestigious journal Cell, researchers from Sweden and Italy show that inflammatory response in Multisystem Inflammatory Syndrome in Children associated with coronavirus disease (COVID-19) differs from the cytokine storm found in severe acute illness, involving autoantibodies at the same time and sharing several features with Kawasaki disease.

8 Sep 2020

High levels of blood clotting factor V in severe COVID‐19 associated with worse outcomes

Patients hospitalized with severe COVID-19 infections who have high levels of the blood clotting protein factor V are at elevated risk for serious injury from blood clots such as deep vein thrombosis or pulmonary embolism, investigators at Massachusetts General Hospital (MGH) have found.

8 Sep 2020

Countries should step-up leprosy prevention initiatives to accelerate decline in new cases

New cases of leprosy are decreasing, but not at the anticipated rate. In order to accelerate the annual decline, countries should screen contacts and treat eligible contacts with single-dose rifampicin, as recommended by the World Health Organization in its guidelines.

8 Sep 2020

Research highlights the effects of confinement due to COVID-19 among pregnant women

Researchers of Medicine and Physical Therapy at the CEU Cardenal Herrera University of Valencia and of the Italian University of Catania, have published the results of the first study on the effects of confinement due to the COVID-19 pandemic among pregnant Spanish women.

8 Sep 2020

Personalized determination of genetic factors may improve treatment for polycythaemia vera

Polycythaemia vera is a chronic malignant disease of the haematopoietic system and is treated with interferon-alpha-based drugs, in most cases with long-lasting success. However, in some cases this therapy is unsuccessful for reasons that are not yet understood.

8 Sep 2020

Focal high-intensity focused ultrasound ablation is an effective treatment for prostate cancer

For some prostate cancer patients, radical treatment (surgery or radiation) are treatment standards. However, these procedures may cause side effects including urinary incontinence or impotency.

8 Sep 2020

Study links brain astrocyte dysfunction to Parkinson’s disease pathology

A new study using induced pluripotent stem cell technology links astrocyte dysfunction to Parkinson’s disease pathology.

8 Sep 2020

Limited gut inflammation in COVID-19

A new study by researchers at the Icahn School of Medicine at Mount Sinai and published on the preprint server medRxiv in September 2020 shows that gut infection with this virus produces primarily mucosal immunity but also a limited inflammatory response.

8 Sep 2020

Therapy News and Research

Migraine patients may benefit from green light therapy

Intravenous iron therapy does not benefit anemic patients during surgery, study finds

Convalescent plasma fails to improve outcome of COVID-19 in India

Combination of stem cell therapy and educational intervention can help kids with ASD

Protein aggregation reduces elasticity of blood vessels in the brain

Novel drug could improve life expectancy and quality for patients with hard-to-treat cancers

High-intensity focused ultrasound technology shows promising outcomes for prostate cancer

New drug can enhance life expectancy and quality for patients with hard-to-treat cancers

New combination therapy helps fight cancer

Environmental and biomedical applications of enzyme inhibitors

Targeted therapy can provide benefits to lung cancer patients with specific gene mutations

Scientists develop a rapid, reliable and low-cost COVID-19 antibody test

Study reveals complex immunology behind MIS-C in children with COVID-19

High levels of blood clotting factor V in severe COVID‐19 associated with worse outcomes

Countries should step-up leprosy prevention initiatives to accelerate decline in new cases

Research highlights the effects of confinement due to COVID-19 among pregnant women

Personalized determination of genetic factors may improve treatment for polycythaemia vera

Focal high-intensity focused ultrasound ablation is an effective treatment for prostate cancer

Study links brain astrocyte dysfunction to Parkinson’s disease pathology

Limited gut inflammation in COVID-19

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News